Stokes shift spectroscopic analysis of multifluorophores for human cancer detection in breast and prostate tissues

Journal of Biomedical Optics

Volumn 18, Issue 1, 2013, Pages

  Pu, Yang ^a   Wang, Wubao ^a   Yang, Yuanlong ^a   Alfano, Robert R ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

cancerous breast and prostate tissue; nicotinamide adenine dinucleotide.; optical biopsy; optimal Stokes shift interval; Stokes shift spectroscopy; tryptophan; collagen

Indexed keywords

NICOTINAMIDE ADENINE DINUCLEOTIDES; OPTICAL BIOPSIES; PROSTATE TISSUE; STOKES SHIFT; STOKES SHIFT SPECTROSCOPY;

AMIDES; AMINO ACIDS; COLLAGEN; DISEASES; HISTOLOGY; LEAST SQUARES APPROXIMATIONS; OPTIMIZATION; SPECTROSCOPIC ANALYSIS; TISSUE; UROLOGY;

TISSUE ENGINEERING;

BIOLOGICAL MARKER; COLLAGEN; NICOTINAMIDE ADENINE DINUCLEOTIDE; TRYPTOPHAN;

ARTICLE; BREAST TUMOR; CHEMISTRY; FEMALE; FLUORESCENCE IMAGING; HUMAN; MALE; METHODOLOGY; PROSTATE TUMOR; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

BIOLOGICAL MARKERS; BREAST NEOPLASMS; COLLAGEN; FEMALE; HUMANS; MALE; NAD; OPTICAL IMAGING; PROSTATIC NEOPLASMS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TRYPTOPHAN;

MLCS; MLOWN;

EID: 84878263867     PISSN: 10833668     EISSN: 15602281     Source Type: Journal    
DOI: 10.1117/1.JBO.18.1.017005     Document Type: Article

References (22)

1. R. R. Alfano et al., "Laser induced fluorescence spectroscopy from native cancerous and normal tissue," IEEE J. Quantum Electron. 20(12), 1507-1511 (1984).
2. Y. Pu et al., "Changes of collagen and NADH in human cancerous and normal prostate tissues studied using fluorescence spectroscopy with selective excitation wavelength," J. Biomed. Opt. 15(4), 047008 (2010).
3. Q. Liu, G. Grant, and T. Vo-Dinh, "Investigation of synchronous fluorescence method in multicomponent analysis in tissue," IEEE J. Quantum Electron. 16(4), 927-940 (2010).
4. J. R. Moffett and M. A. Namboodiri, "Review article: tryptophan and the immune response," Immunol. Cell Biol. 81(4), 247-265 (2003). (Pubitemid 36904332)
5. D. K. Bird et al., "Metabolic mapping of MCF10A human breast cells via multiphoton fluorescence lifetime imaging of the coenzyme NADH," Cancer Res. 65(19), 8766-8773 (2005). (Pubitemid 41377365)
6. Y. Pu et al., "Native fluorescence spectroscopic evaluation of chemotherapeutic effects on malignant cells using nonnegative matrix factorization analysis," Technol. Cancer Res. Treat. 10(2), 113-120 (2011).
7. Y. Pu et al., "Time-resolved spectral wing emission kinetics and optical imaging of human cancerous and normal prostate tissues," Opt. Commun. 282(21), 4308-4314 (2009).
8. Y. Pu et al., "Stokes shift spectroscopy highlights differences of cancerous and normal human tissues," Opt. Lett. 37(16), 3360-3362 (2012).
9. J. Ebenezar et al., "Stokes shift spectroscopy pilot study for cancerous and normal prostate tissues," Appl. Opt. 51(16), 3642-3649 (2012).
10. A. De Juan and R. Tauler, "Multivariate curve resolution (MCR) from 2000: progress in concepts and applications," Crit. Rev. Anal. Chem. 36(3-4), 163-176 (2006). (Pubitemid 44889524)
11. L. Parra, "Linear discrimination single trial detection in EEG/MEG- biomedical signal processing and signal modeling," http://bme.ccny .cuny.edu/faculty/parra/teaching/biomed-dsp/class8.pdf.
12. A. Shmilovici, "Incomplete tumor volume reduction may improve cancer prognosis," Med. Hypotheses 68(6), 1236-1239 (2007). (Pubitemid 46498452)
13. M. Sauer, J. Hofkens, and J. Enderlein, "Fluorophores and fluorescent labels," Chapter 2 in Handbook of Fluorescence Spectroscopy and Imaging: From Single Molecules to Ensembles, pp. 31-60,Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany (2011).
14. M.-A. Mycek and B. W. Pogue, Eds., Handbook of Biomedical Fluorescence, Marcel Dekker, New York (2003).
15. A. Baici et al., "Fluorescence properties of reduced thionicotinamide- adenine dinucleotide and of its complex with octopine dehydrogenase," Eur. J. Biochem. 83(2), 601-607 (1978). (Pubitemid 8270621)
16. J. R. Lakowicz, Principles of Fluorescence Spectroscopy, Kluwer Academic, Dordrecht, The Netherlands (1999).
17. H. J. G. Bloom and W. W. Richardson, "Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years," Br. J. Cancer 11(3), 359-377 (1957).
18. G. Fenhalls, D. M. Dent, and M. I. Parker, "Breast tumor cell-induced down-regulation of type I collagen mRNA in fibroblasts," Br. J. Cancer 81(7), 1142-1149 (1999).
19. I. Balslev et al., "The Nottingham prognostic index applied to 9,149 patients from the studies of the Danish Breast Cancer Cooperative Group (DBCG)," Breast Canc. Res. Treat. 32(3), 281-290 (1994). (Pubitemid 24351375)
20. J. F. Simpson et al., "Prognostic value of histologic grade and proliferative activity in axillary node-positive breast cancer: results from the Eastern Cooperative Oncology Group Companion Study, EST 4189," J. Clin. Oncol. 18(10), 2059-2069 (2000). (Pubitemid 30324359)
21. A. S. Haka et al., "Diagnosing breast cancer by using Raman spectroscopy," PNAS 102(35), 12371-12376 (2005). (Pubitemid 41266366)
22. Y. Sun et al., "Biomarkers spectral subspace for cancer detection," J. Biomed. Opt. 17(10), 107005 (2012).